Takeda Pharmaceutical Co Ltd
XBER:TKD
Wall Street
Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
TKD
is 25.32 EUR
with a low forecast of 21.56 EUR and a high forecast of 30.21 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TKD's stock price target?
Price Target
25.32
EUR
According to Wall Street analysts, the average 1-year price target for
TKD
is 25.32 EUR
with a low forecast of 21.56 EUR and a high forecast of 30.21 EUR.
What is Takeda Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
0%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's revenue is
9%.
The projected
CAGR
for the next 3 years is
0%.
What is Takeda Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-3%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's operating income is
6%.
The projected
CAGR
for the next 2 years is
-3%.
What is Takeda Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
46%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's net income is
-1%.
The projected
CAGR
for the next 3 years is
46%.
